Literature DB >> 27400929

β-Adrenergic receptor gene expression in HIV-associated neurocognitive impairment and encephalitis: implications for MOR-1K subcellular localization.

Seth M Dever1,2, Myosotys Rodriguez2, Nazira El-Hage3,4.   

Abstract

We previously reported that mRNA expression of the unique alternatively spliced OPRM1 isoform μ-opioid receptor-1K (MOR-1K), which exhibits excitatory cellular signaling, is elevated in HIV-infected individuals with combined neurocognitive impairment (NCI) and HIV encephalitis (HIVE). It has recently been shown that the β2-adrenergic receptor (β2-AR) chaperones MOR-1K, normally localized intracellularly, to the cell surface. Here, we found mRNA expression of the adrenoceptor beta 2 (ADRB2) gene is also elevated in NCI-HIVE individuals, as well as that β2-AR protein expression is elevated in HIV-1-infected primary human astrocytes treated with morphine, and discuss the implications for MOR-1K subcellular localization in this condition.

Entities:  

Keywords:  Central nervous system; HIV encephalitis; HIV-associated neurocognitive disorders; Splice variant; β-Adrenergic receptor; μ-Opioid receptor

Mesh:

Substances:

Year:  2016        PMID: 27400929      PMCID: PMC5228594          DOI: 10.1007/s13365-016-0464-1

Source DB:  PubMed          Journal:  J Neurovirol        ISSN: 1355-0284            Impact factor:   2.643


  19 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  Olfactory receptor surface expression is driven by association with the beta2-adrenergic receptor.

Authors:  Chris Hague; Michelle A Uberti; Zhongjian Chen; Cristina F Bush; Seth V Jones; Kerry J Ressler; Randy A Hall; Kenneth P Minneman
Journal:  Proc Natl Acad Sci U S A       Date:  2004-09-03       Impact factor: 11.205

3.  Synergistic neurotoxicity of opioids and human immunodeficiency virus-1 Tat protein in striatal neurons in vitro.

Authors:  J A Gurwell; A Nath; Q Sun; J Zhang; K M Martin; Y Chen; K F Hauser
Journal:  Neuroscience       Date:  2001       Impact factor: 3.590

4.  Synergistic increases in intracellular Ca2+, and the release of MCP-1, RANTES, and IL-6 by astrocytes treated with opiates and HIV-1 Tat.

Authors:  Nazira El-Hage; Julie A Gurwell; Indrapal N Singh; Pamela E Knapp; Avindra Nath; Kurt F Hauser
Journal:  Glia       Date:  2005-04-15       Impact factor: 7.452

5.  Differential expression and HIV-1 regulation of μ-opioid receptor splice variants across human central nervous system cell types.

Authors:  Seth M Dever; Ruqiang Xu; Sylvia Fitting; Pamela E Knapp; Kurt F Hauser
Journal:  J Neurovirol       Date:  2012-04-20       Impact factor: 2.643

6.  Heterodimerization and cross-desensitization between the mu-opioid receptor and the chemokine CCR5 receptor.

Authors:  Chongguang Chen; Jin Li; George Bot; Imre Szabo; Thomas J Rogers; Lee-Yuan Liu-Chen
Journal:  Eur J Pharmacol       Date:  2004-01-12       Impact factor: 4.432

7.  Distinct biological and serological properties of human immunodeficiency viruses from the brain.

Authors:  C Cheng-Mayer; J A Levy
Journal:  Ann Neurol       Date:  1988       Impact factor: 10.422

8.  Differing roles of autophagy in HIV-associated neurocognitive impairment and encephalitis with implications for morphine co-exposure.

Authors:  Seth M Dever; Myosotys Rodriguez; Jessica Lapierre; Blair N Costin; Nazira El-Hage
Journal:  Front Microbiol       Date:  2015-07-06       Impact factor: 5.640

9.  Structural and functional interactions between six-transmembrane μ-opioid receptors and β2-adrenoreceptors modulate opioid signaling.

Authors:  Alexander Samoshkin; Marino Convertino; Chi T Viet; Jeffrey S Wieskopf; Oleg Kambur; Jaclyn Marcovitz; Pinkal Patel; Laura S Stone; Eija Kalso; Jeffrey S Mogil; Brian L Schmidt; William Maixner; Nikolay V Dokholyan; Luda Diatchenko
Journal:  Sci Rep       Date:  2015-12-11       Impact factor: 4.379

10.  Expansion of the human mu-opioid receptor gene architecture: novel functional variants.

Authors:  Svetlana A Shabalina; Dmitri V Zaykin; Pavel Gris; Aleksey Y Ogurtsov; Josee Gauthier; Kyoko Shibata; Inna E Tchivileva; Inna Belfer; Bikashkumar Mishra; Carly Kiselycznyk; Margaret R Wallace; Roland Staud; Nikolay A Spiridonov; Mitchell B Max; David Goldman; Roger B Fillingim; William Maixner; Luda Diatchenko
Journal:  Hum Mol Genet       Date:  2008-12-22       Impact factor: 6.150

View more
  4 in total

1.  The role of catecholamines in HIV neuropathogenesis.

Authors:  R Nolan; P J Gaskill
Journal:  Brain Res       Date:  2018-04-27       Impact factor: 3.252

Review 2.  Alternative splicing isoforms in health and disease.

Authors:  Hyoung Kyu Kim; Michael Huy Cuong Pham; Kyung Soo Ko; Byoung Doo Rhee; Jin Han
Journal:  Pflugers Arch       Date:  2018-03-13       Impact factor: 3.657

3.  Cerebrospinal Fluid Norepinephrine and Neurocognition in HIV and Methamphetamine Dependence.

Authors:  Rowan Saloner; Mariana Cherner; Jennifer E Iudicello; Robert K Heaton; Scott L Letendre; Ronald J Ellis
Journal:  J Acquir Immune Defic Syndr       Date:  2020-10-01       Impact factor: 3.771

4.  Blockade of beta adrenergic receptors protects the blood brain barrier and reduces systemic pathology caused by HIV-1 Nef protein.

Authors:  Jocelyn Rivera-Ortiz; Jessalyn Pla-Tenorio; Myrella L Cruz; Krystal Colon; Jaileene Perez-Morales; Julio A Rodriguez; Jorge Martinez-Sicari; Richard J Noel
Journal:  PLoS One       Date:  2021-11-16       Impact factor: 3.752

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.